Trials / Completed
CompletedNCT05549791
A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy
A Domestic, Prospective, Non-interventional Study of Remimazolam Tosilate for Injection in the Real-world for General Anesthesia and Fiberoptic Bronchoscopy Sedation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,285 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This is a non-interventional study of remazolam toluenesulfonate (rebenin ®) for injection in Chinese patients. A total of 1000 patients were enrolled in this study based on the preliminary safety assessment of rebenin ®, and all safety information was obtained
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remimazolam Tosilate for Injection | Remimazolam Tosilate for Injection |
Timeline
- Start date
- 2022-08-18
- Primary completion
- 2024-06-21
- Completion
- 2024-06-21
- First posted
- 2022-09-22
- Last updated
- 2026-01-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05549791. Inclusion in this directory is not an endorsement.